Lamivudine dolutegravir tablets are commonly used for the initial treatment of adult patients infected with the HIV-1 virus. The requirements for use are that the patient has not received prior antiretroviral therapy and is not resistant to lamivudine and dolutegravir. Prior to initiating treatment, the plasma viral load should be less than 500,000 copies/ml and free of hepatitis B virus infection. Treatment rapidly suppresses viral replication and protects uninfected cells from infection. There may be some adverse reactions during treatment, such as psychiatric symptoms, gastrointestinal symptoms, hepatitis, itchy skin, and systemic diseases. In case of serious adverse reactions, use of the drug is prohibited. The main contraindication to lamivudine dolutegravir tablets is that it should not be used by patients who are allergic to the drug. And it is forbidden to combine dolutegravir with piracetam, which can cause serious adverse reactions. Lamivudine Dotiravir Tablets can be used as many HIV diagnostics and treatments, as each individual is different.HIV treatment must be done with caution, so always consult your doctor before taking the medication, and use it under your doctor’s supervision.